Kernal Biologics Funding: $36M Raised, Series A (2022)
Kernal Biologics is based in Cambridge. It has raised $36M in total funding. Latest round: Series A.
Kernal Biologics funding overview
Kernal Biologics is based in Cambridge. Kernal Biologics has raised $36M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in July 2022. The round record for Kernal Biologics runs through 2022; nothing later has been disclosed. Investors on record include Hummingbird Ventures, Amgen Ventures, HBM Genomics, Civilization Ventures, NASA, Boeing and 1 others. 7 distinct backers are named across the disclosed rounds.
Kernal Biologics has raised $36M in total disclosed funding across the rounds on record.
Who has invested in Kernal Biologics?
Hummingbird Ventures, Amgen Ventures, HBM Genomics, Civilization Ventures, NASA, Boeing are named among the investors backing Kernal Biologics.
What was the latest Kernal Biologics funding round?
The most recent disclosed round is a Series A, announced in July 2022.
Where is Kernal Biologics based?
Kernal Biologics is based in Cambridge.
When did Kernal Biologics last raise?
The last disclosed Kernal Biologics round closed in July 2022 at Series A.
Round data for Kernal Biologics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Cambridge and backer lists below.
